Publications by authors named "Pingqing He"

Claim this Profile
E
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.
Ke-Da Yu, Fu-Gui Ye, Min He, Lei Fan, Ding Ma, Ping-Qing He, Cheng Wang, Zhen-Zhou Shen

JAMA Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial.
Junjie Li, Keda Yu, Da Pang, Changqin Wang, Jun Jiang, Suisheng Yang, Yuan Sheng, Qi He, Guosheng Ren, Xinzheng Li, Ouchen Wang, Pingqing He, Binghe Xu

J Clin Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway.
Xuexiang Ying, Anling Huang, Yajing Xing, Liping Lan, Zhengfang Yi, Pingqing He

Sci China Life Sci· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-137 inhibits BMP7 to enhance the epithelial-mesenchymal transition of breast cancer cells.
Xuexiang Ying, Yunpo Sun, Pingqing He

Oncotarget· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone Morphogenetic Protein-7 Inhibits EMT-Associated Genes in Breast Cancer.
Xuexiang Ying, Yunpo Sun, Pingqing He

Cell Physiol Biochem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of CEACAM1 in breast cancer.
Changcheng Yang, Pingqing He, Yiwen Liu, Yiqing He, Cuixia Yang

Acta Biochim Biophys Sin (Shanghai)· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assay of serum CEACAM1 as a potential biomarker for breast cancer.
Changcheng Yang, Pingqing He, Yiwen Liu, Yiqing He, Cuixia Yang

Clin Chim Acta· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway.
Cuixia Yang, Linyan He, Pingqing He, Yiwen Liu, Wenjuan Wang, Yiqing He

Med Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluroan-regulated lymphatic permeability through S1P receptors is crucial for cancer metastasis.
Mengsi Yu, Pingqing He, Yiwen Liu, Yiqing He, Yan Du

Med Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancer.
Ying Lin, Jianlun Liu, Xiaohua Zhang, Li Li, Rui Hu, Dedian Chen, Shengrong Sun, Pingqing He, Zheli Xu, Zhongsheng Tong, Helong Zhang, Guosheng Feng, Shenming Wang

Cancer Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of mammography and ultrasound in women with breast disease: a receiver operating characteristic analysis.
Xuexiang Ying, Yanping Lin, Xiaotian Xia, Bin Hu, Zhuhua Zhu, Pingqing He

Breast J· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients' persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer.
Ke-Da Yu, Ying Zhou, Guang-Yu Liu, Bin Li, Ping-Qing He, Shen-Ming Wang, Hong Zheng, Sheng-Rong Sun, Zhen-Zhou Shen

Breast Cancer Res Treat· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
Wen-Feng Li, Zhen Hu, Nan-Yan Rao, Chuang-Gui Song, Bin Zhang, Yong-Sheng Wang, Ping-Qing He, Kun-Wei Shen, Zhen-Zhou Shen

Breast Cancer Res Treat· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Neoadjuvant chemotherapy with docetaxel plus epirubicin for locally advanced breast cancer: a multi-center phase II study].
Zhen-zhou Shen, Guang-yu Liu, Feng-xi Su, Ping-qing He, Ming-tian Yang, Yuan Sheng

Zhonghua Zhong Liu Za Zhi· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis